Meta-analysis of inhaled corticosteroids response in children with asthma. Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics Year: 2019
Effects of inhaled corticosteroids on cough in asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 347s Year: 2004
Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis Source: Eur Respir J, 54 (1) 1801896; 10.1183/13993003.01896-2018 Year: 2019
Effects of montelukast on tapering inhaled corticosteroids in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 407s Year: 2002
Effects of montelukast on tapering inhaled corticosteroids in patients with asthma Source: Eur Respir J 2001; 18: Suppl. 33, 260s Year: 2001
Genome-wide association study of asthma exacerbations despite inhaled corticosteroid use Source: Eur Respir J, 57 (5) 2003388; 10.1183/13993003.03388-2020 Year: 2021
Cost-minimisation analysis of two different inhaled steroids in persistent bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 302s Year: 2002
Pharmacoeconomic aspects of inhaled corticocteroids in the treatment of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 98s Year: 2001
Determinants of adherence to inhaled corticosteroids in children with asthma Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010
Comparison of inhaled corticosteroid combined with theophylline and double-dose inhaled corticosteroid in moderate-severe persistent asthma Source: Eur Respir J 2004; 24: Suppl. 48, 127s Year: 2004
Genome-wide association study of asthma exacerbations in European children treated with inhaled corticosteroids Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017
Pharmacogenetics of inhaled corticosteroid response in adults with asthma Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020
Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2010
Measures to assess adherence to inhaled corticosteroids for asthma Source: Eur Respir J 2003; 22: Suppl. 45, 294s Year: 2003
Effects of inhaled corticosteroids on asthmatic inflammation: The FeNOtype trial Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012
Reduction of inhaled corticosteroids in asthmatic children Source: Eur Respir J 2007; 30: Suppl. 51, 616s Year: 2007
Efficacy of low dose theophylline and inhaled corticosteroids in smokers with asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008
Additional anti-inflammatory effects of inhaled budesonide/formoterol over inhaled budesonide in subjects with atopic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 441s Year: 2006
Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020
Concomitant use of low-dose inhaled corticosteroids and a long-acting bronchodilatator visavi doubling the dose of inhaled corticosterod in asthma patients Source: Eur Respir J 2001; 18: Suppl. 33, 98s Year: 2001